文献速递复苏、休克与脓毒症消化、代谢与肾脏急症重症综合管理与镇静镇痛

术后医疗保健相关腹腔感染感染性休克与90天死亡率的决定因素:Sepsi-Pop研究,一项多中心回顾性研究

Determinants of Septic Shock and 90-Day Mortality After Postoperative Healthcare-Associated Intra-Abdominal Infection: The Sepsi-Pop Study, a Multicenter Retrospective Study.
PubMed 文献 · Shock · 2026-03-30
一句话结论术后医疗保健相关腹腔感染患者中,真菌定植是感染性休克(OR 4.37)和90天死亡率(OR 14.36)的共同独立危险因素,而有效感染源控制与死亡率降低独立相关(OR 0.22)。

这项在法国三个ICU开展的多中心回顾性研究纳入2009至2021年间初始腹部手术后发生医疗保健相关腹腔感染的271例成人患者,其中75.6%合并癌症,感染性休克发生率为57%,90天死亡率为14.4%。多因素logistic回归显示,感染性休克的独立预测因素包括ASA分级>II、无癌症、48小时内抗生素暴露、真菌定植和大肠埃希菌菌血症,女性为保护因素;90天死亡率的独立相关因素包括ASA分级>II、年龄、再手术时SOFA评分、真菌定植和治疗失败,而有效感染源控制为保护因素。作者认为,早期识别高危人群并及时给予针对性干预可能改善术后医疗保健相关腹腔感染的结局。

要点

  • 术后医疗保健相关腹腔感染患者感染性休克发生率达57%,90天死亡率为14.4%(271例,法国3个ICU,2009-2021年)。
  • 真菌定植是感染性休克(OR 4.37,95%CI 1.23-20.94)和90天死亡率(OR 14.36,95%CI 2.50-89.21)的共同独立危险因素。
  • 有效感染源控制与90天死亡率降低独立相关(OR 0.22,95%CI 0.04-0.84)。
  • 治疗失败与90天死亡率强烈相关(OR 12.15,95%CI 2.09-81.90),再手术时SOFA评分每升高1分死亡风险增加(OR 1.20,95%CI 1.05-1.38)。
  • ASA分级>II同时预测感染性休克(OR 2.48)和90天死亡率(OR 2.83),女性感染性休克风险较低(OR 0.57)。

适用人群与场景

  • 2009至2021年间在法国三个ICU收治的、初始腹部手术后发生医疗保健相关腹腔感染的成人患者(271例,中位年龄65岁,75.6%合并癌症)。

研究设计与关键结果

  • 研究类型为多中心回顾性研究,纳入271例成人患者,中位年龄65(55-74)岁,75.6%合并癌症。
  • 感染性休克发生率为57%(154/271),90天死亡率为14.4%。
  • 感染性休克的独立预测因素:ASA分级>II(OR 2.48,95%CI 1.42-4.40)、无癌症(OR 2.03,95%CI 1.03-4.12)、48小时内抗生素暴露(OR 1.85,95%CI 1.03-3.38)、真菌定植(OR 4.37,95%CI 1.23-20.94)、大肠埃希菌菌血症(OR 3.25,95%CI 1.15-10.78);女性为保护因素(OR 0.57,95%CI 0.33-0.99)。
  • 90天死亡率的独立相关因素:ASA分级>II(OR 2.83,95%CI 1.08-7.97)、年龄(OR 1.10,95%CI 1.05-1.16)、再手术时SOFA评分(OR 1.20,95%CI 1.05-1.38)、真菌定植(OR 14.36,95%CI 2.50-89.21)、治疗失败(OR 12.15,95%CI 2.09-81.90);有效感染源控制为保护因素(OR 0.22,95%CI 0.04-0.84)。

证据类型、等级与局限

  • 证据类型:多中心回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,早期识别高危人群并及时给予针对性干预可能改善术后医疗保健相关腹腔感染的结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Healthcare-associated intra-abdominal infections (HC-IAIs) after abdominal surgery are a major cause of sepsis in intensive care units. While predictors of mortality are well established, the determinants of septic shock remain insufficiently defined.

METHODS: This retrospective multicenter study included all adult patients who developed HC-IAI after initial abdominal surgery between 2009 and 2021 in three French intensive care units. Clinical, microbiological, and management data were collected. Independent predictors of septic shock and 90-day mortality were identified using multivariate logistic regression.

RESULTS: Among 271 patients [median age 65 (55-74) years, 75.6% with cancer], septic shock occurred in 154 (57%) and 90-day mortality was 14.4%. Independent predictors of septic shock were American Society of Anesthesiologists physical status classification >II [odds ratio (OR): 2.48 (1.42-4.40)], absence of cancer [OR: 2.03 (1.03-4.12)], antibiotic exposure within 48 hours [OR: 1.85 (1.03-3.38)], fungal colonization [OR: 4.37 (1.23-20.94)], and Escherichia coli bacteremia [OR: 3.25 (1.15-10.78)]. Female sex was protective [OR: 0.57 (0.33-0.99)]. The 90-day mortality was independently associated with American Society of Anesthesiologists physical status classification >II [OR: 2.83 (1.08-7.97)], age [OR: 1.10 (1.05-1.16)], Sequential Organ Failure Assessment at reoperation [OR: 1.20 (1.05-1.38)], fungal colonization [OR: 14.36 (2.50-89.21)], and treatment failure [OR: 12.15 (2.09-81.90)], whereas effective source control was protective [OR: 0.22 (0.04-0.84)].

CONCLUSIONS: Determinants of septic shock and 90-day mortality partly overlap but differ in therapeutic implications. Fungal colonization and patient frailty emerged as shared risk factors, while mortality was influenced by age, organ failure, and inadequate source control. Early identification of high-risk profiles and timely, targeted interventions may improve outcomes in postoperative HC-IAI.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Mokart D, Bianchi A, Ronflé R, et al. Determinants of Septic Shock and 90-Day Mortality After Postoperative Healthcare-Associated Intra-Abdominal Infection: The Sepsi-Pop Study, a Multicenter Retrospective Study. Shock. 2026. PMID: 41949841. doi:10.1097/SHK.0000000000002851

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。